Yaowen D. Zhang
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Sintilimab Plus Axitinib for Advanced Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Phase 2 Nonrandomized Clinical Trial.
Journal: JAMA oncology
Published: August 14, 2025
First-line systemic therapy in patients with metastatic or locally advanced urothelial carcinoma: a systematic review and network meta-analysis of randomized controlled trials.
Journal: Therapeutic advances in medical oncology
Published: February 21, 2025
Research progress of novel bone turnover markers in osteoporosis
Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Published: December 22, 2024
Metabolic tumor parameters on 18F-FDG PET/CT can predict the expression of PD-L1 and prognosis in patients with fumarate hydratase-deficient renal cell carcinoma.
Journal: Annals of nuclear medicine
Published: December 11, 2024
Nanozymes in cancer immunotherapy: metabolic disruption and therapeutic synergy.
Journal: Journal of materials chemistry. B
Published: August 23, 2024
Tertiary lymphoid structures potentially promote immune checkpoint inhibitor response in SMARCB1-deficient medullary renal cell carcinoma.
Journal: NPJ precision oncology
Published: July 11, 2024
Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma.
Journal: Molecular cancer
Published: April 21, 2024
Enhancing dental education: integrating online learning in complete denture rehabilitation.
Journal: BMC medical education
Published: April 12, 2024
Case report: Synchronous prostate cancer and renal cell carcinoma with prostate cancer-origin metastases to adrenal and renal hilar lymph nodes.
Journal: Frontiers in oncology
Published: April 08, 2024
The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Journal: Cancer treatment reviews
Published: March 07, 2024
Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets.
Journal: Nature communications
Published: March 06, 2024
Last Updated: 09/26/2026